# Precigen, Inc. (PGEN) insider trading

> In the 12 months to Nov 7, 2026, 6 PGEN insiders reported open-market sales of $43.6M across 13 filings; one director bought $24.7K.

Canonical: https://massive.com/quote/pgen/insider-trading
Latest filing: 2026-09-24 (last 12 months; source: SEC EDGAR)
Source: Massive (https://massive.com/docs/llms.txt)

## Summary

| Measure | Value | Detail |
| --- | --- | --- |
| Open-market sales | $43.6M | 13 filings · 6 insiders |
| Open-market purchases | $24.7K | 1 filing · Nancy H. Agee, Director |
| Pre-arranged sales (10b5-1) | 8 of 13 | $5.4M of $43.6M sold (12%) |

## Open-market trades by insider

| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
| --- | --- | --- | --- | --- | --- | --- |
| Randal J. Kirk | Director | $36.0M | — | 3 | — | 2026-03-31 |
| Jeffrey B. Kindler | Director | $2.2M | — | 2 | — | 2026-08-28 |
| Helen Sabzevari | President and CEO | $2.0M | — | 1 | 100% of sales | 2026-07-01 |
| Harry Thomasian JR. | Chief Financial Officer | $1.7M | — | 2 | 100% of sales | 2026-07-31 |
| Rutul R. Shah | Chief Operating Officer | $1.1M | — | 4 | 100% of sales | 2026-08-25 |
| Phil Tennant | Chief Commercial Officer | $593.7K | — | 1 | 100% of sales | 2026-08-25 |
| Nancy H. Agee | Director | — | $24.7K | 1 | — | 2026-08-25 |

## Open-market trades by filing

14 filings in the last 12 months, newest first.

| Filed | Traded | Insider | Role | Type | Shares | Avg price | Value | Held after | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 2026-08-28 | 2026-08-26 | Jeffrey B. Kindler | Director | Sale | 185,000 | $7.44 | $1.4M | 17,100 | — |
| 2026-08-25 | 2026-08-25 | Phil Tennant | Chief Commercial Officer | Sale (10b5-1) | 79,166 | $7.50 | $593.7K | 141,992 | — |
| 2026-08-25 | 2026-08-21 | Rutul R. Shah | Chief Operating Officer | Sale (10b5-1) | 50,000 | $7.50 | $375.0K | 468,865 | — |
| 2026-08-25 | 2026-08-21 | Nancy H. Agee | Director | Purchase | 3,411 | $7.23 | $24.7K | 309,187 | — |
| 2026-08-07 | 2026-08-06 | Rutul R. Shah | Chief Operating Officer | Sale (10b5-1) | 32,739 | $6.86 | $224.6K | 465,012 | — |
| 2026-08-03 | 2026-08-03 | Rutul R. Shah | Chief Operating Officer | Sale (10b5-1) | 33,772 | $6.50 | $219.5K | 497,751 | — |
| 2026-07-31 | 2026-07-31 | Harry Thomasian JR. | Chief Financial Officer | Sale (10b5-1) | 100,000 | $6.06 | $606.0K | 254,535 | — |
| 2026-07-01 | 2026-06-29 | Helen Sabzevari | President and CEO | Sale (10b5-1) | 346,836 | $5.89 | $2.0M | 3,768,872 | — |
| 2026-07-01 | 2026-06-29 | Rutul R. Shah | Chief Operating Officer | Sale (10b5-1) | 42,924 | $5.85 | $251.1K | 497,751 | — |
| 2026-07-01 | 2026-06-29 | Harry Thomasian JR. | Chief Financial Officer | Sale (10b5-1) | 200,000 | $5.57 | $1.1M | 354,535 | — |
| 2026-03-31 | 2026-03-30 | Randal J. Kirk | Director | Sale | 4,772,781 | $3.30 | $15.8M | Multiple accounts | — |
| 2025-12-22 | 2025-12-22 | Randal J. Kirk | Director | Sale | 1,900,036 | $4.18 | $7.9M | Multiple accounts | — |
| 2025-12-16 | 2025-12-12 | Jeffrey B. Kindler | Director | Sale | 235,467 | $3.63 | $855.9K | 110,603 | — |
| 2025-11-21 | 2025-11-19 | Randal J. Kirk | Director | Sale | 2,966,293 | $4.14 | $12.3M | 5,554,244 | — |

## Other insider activity (not market trades)

- Option exercises: 33 records
- Tax withholding: 5 records
- Tax withholding (sold to cover): 5 records
- Grants and awards: 8 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

## How to read this page

- **Open-market purchase or sale**: A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- **Pre-arranged (10b5-1)**: The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- **Filing date**: Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.

## FAQ

### Has Precigen, Inc.'s CEO sold stock?

Yes. Helen Sabzevari (CEO) sold 346,836 shares ($2.0M) in Jul 2026, all under a pre-arranged 10b5-1 plan.

### How current is PGEN’s insider data?

These are PGEN Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

### What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

## Live data

This page joins two Massive endpoints: Form 4 filings and daily prices. The PGEN Form 4 request:

- `GET https://api.massive.com/stocks/filings/vX/form-4?tickers=PGEN&filing_date.gte=2025-11-07&sort=filing_date.desc&limit=500`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Precigen, Inc. (PGEN) stock price](https://massive.com/quote/pgen.md)
- [Recent insider trading](https://massive.com/quote/insider-trading.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms